CROWN and BRIGHTSTAR Studies: Latest Data Insights
Panelists discuss the key findings from the latest data from the CROWN and BRIGHTSTAR studies, emphasizing efficacy end points and comparing the effectiveness of these regimens with that of others in the treatment landscape for ALK-positive NSCLC.
- Dr Bestvina: Please discuss the key findings from the latest data for the CROWN/BRIGHTSTAR studies.
- CROWN
- Please specifically discuss and emphasize efficacy end points here. How does the efficacy of this regimen compare with that of others in this space?
- BRIGHTSTAR
Related Content:
